Medicine

We’ll find out how cigarette manufacturers made some processed food addicting. Then, Judy Govatos talks about death with dignity. Opera Philadelphia's David Devan also joins.

Philadelphia's Mütter Museum is wrestling with ethical questions about its displays of human remains. Also, the invention of the pocket and the first emoticon :-).

Narcan is a well-known brand of naloxone, a medication that can reverse drug overdoses if someone has taken opioid pills, heroin, or fentanyl.

The docuseries explores why racial diversity is key to clinical trials, while addressing a history of mistrust among Black Americans.

After a controversial decision to rethink its collection of medical pathologies, the Mütter will launch a 2-year public discussion about human remains.

New COVID-19 vaccine recommendations come out Tuesday. We hear from Dr. Paul Offit, a member of the FDA advisory panel, about the latest guidelines released by the CDC.

Experts say they offer good protection against current COVID variants. Who should get them, and when's the best time to roll up your sleeve?

The agency’s director is expected to sign off on the panel’s recommendation and the vaccines could be available this week.

The vaccines from Moderna and Pfizer and its partner BioNTech were approved Monday for people 12 and older.

The new payouts are from a second wave of national opioid lawsuit settlements with Teva, Allergan, CVS, Walgreens, and Walmart.

Though still lower than past years, cases and hospitalizations have been creeping up. Happily, tests are still readily accessible.

Scientists have produced the first data indicating that a variant that has raised alarm is unlikely to pose a big new COVID-19 threat.

Philly hospital leaders, city officials look to spread the word about changes to insulin costs for Medicare patients under the Inflation Reduction Act.

The government will negotiate new prices for the commonly prescribed drugs, but the cuts won't take effect until 2026.

The university’s School of Biomedical Engineering officials say that the new academic program offers more workforce training for the growing cell and gene therapy industry.